Brought to you by WBIW News and Network Indiana
Last updated on Wednesday, August 19, 2009
(INDIANAPOLIS, IN) - Indianapolis-based Eli Lilly is stopping development of an osteoporosis drug.
The pharmaceutical-maker says a study has shown Arzoxifene met its primary objectives, but the results did not indicate the drug would "represent a meaningful advancement in the treatment of osteoporosis."
© Ad-Venture Media, Inc. All Rights Reserved.
Click here to go back to previous page